drugset / Trial / NCT06142656

Efficacy of Vildagliptin Versus Metformin in Poly Cystic Ovary Syndrome

NCT06142656

Phase 2/3 Recruiting 60 enrolled October 6 University
RandomizedParallel-groupSingle-blindTreatment

Summary

Polycystic ovary syndrome (PCOS) is an endocrine disorder that affects approximately 10-20% of women of reproductive age, Management strategies for PCOS include lifestyle modifications such as diet and physical activity that are the first-line approach to treatment; however, they are reported to be minimally effective in reducing weight or treating PCOS-related symptoms.Pharmacological options are also available; however, they are not explicitly approved for PCOS treatment as they have been primarily used to treat other conditions such as T2DM

Timeline

Start
2023-11-25
Primary completion
2025-12-01
Completion
2026-02-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metformin Small molecule 850 mg Oral
Comparator Vildagliptin Other / unclassified 50 mg Oral